BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 61 filers reported holding BEAM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $713 | -24.0% | 29,634 | +0.9% | 0.00% | 0.0% |
Q2 2023 | $938 | -32.1% | 29,371 | -34.9% | 0.00% | -50.0% |
Q1 2023 | $1,381 | -36.3% | 45,092 | -18.6% | 0.00% | -33.3% |
Q4 2022 | $2,167 | -99.9% | 55,407 | +7.2% | 0.00% | -25.0% |
Q3 2022 | $2,463,000 | +26.9% | 51,698 | +3.1% | 0.00% | +33.3% |
Q2 2022 | $1,941,000 | -22.5% | 50,148 | +14.8% | 0.00% | 0.0% |
Q1 2022 | $2,503,000 | -21.6% | 43,689 | +9.1% | 0.00% | 0.0% |
Q4 2021 | $3,191,000 | -11.9% | 40,039 | -3.8% | 0.00% | -25.0% |
Q3 2021 | $3,622,000 | -41.6% | 41,622 | -13.7% | 0.00% | -33.3% |
Q2 2021 | $6,207,000 | +69.9% | 48,228 | +5.6% | 0.01% | +50.0% |
Q1 2021 | $3,654,000 | -2.0% | 45,650 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $3,727,000 | +353.4% | 45,650 | +36.7% | 0.00% | +300.0% |
Q3 2020 | $822,000 | +65.7% | 33,400 | +88.7% | 0.00% | 0.0% |
Q2 2020 | $496,000 | +316.8% | 17,700 | +168.2% | 0.00% | – |
Q1 2020 | $119,000 | – | 6,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |